To determine whether EXOs prevent the endothelial dysfunction by LPS stimulation through the regulation of inflammatory response signaling pathways, we detected Nuclear Factor Kappa B (NF-κB) signaling activation. The gene discussed is NFKB1; the disease is endothelial dysfunction.